These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16274992)

  • 21. Molecular docking study and development of an empirical binding free energy model for phosphodiesterase 4 inhibitors.
    Oliveira FG; Sant'Anna CM; Caffarena ER; Dardenne LE; Barreiro EJ
    Bioorg Med Chem; 2006 Sep; 14(17):6001-11. PubMed ID: 16843671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-based design and synthesis of tricyclic IAP (Inhibitors of Apoptosis Proteins) inhibitors.
    Hird AW; Aquila BM; Block MH; Hennessy EJ; Kamhi VM; Omer CA; Laing NM; Saeh JC; Sha L; Yang B
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1820-4. PubMed ID: 24631189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A strategy of employing aminoheterocycles as amide mimics to identify novel, potent and bioavailable soluble epoxide hydrolase inhibitors.
    Shen HC; Ding FX; Deng Q; Xu S; Tong X; Zhang X; Chen Y; Zhou G; Pai LY; Alonso-Galicia M; Roy S; Zhang B; Tata JR; Berger JP; Colletti SL
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5716-21. PubMed ID: 19700315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery and synthesis of a novel series of quinoline-based thrombin receptor (PAR-1) antagonists.
    Clasby MC; Chackalamannil S; Czarniecki M; Doller D; Eagen K; Greenlee WJ; Lin Y; Tsai H; Xia Y; Ahn HS; Agans-Fantuzzi J; Boykow G; Chintala M; Foster C; Bryant M; Lau J
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1544-8. PubMed ID: 16380251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel tricyclic azepine derivatives: Biological evaluation of pyrimido[4,5-b]-1,4-benzoxazepines, thiazepines, and diazepines as inhibitors of the epidermal growth factor receptor tyrosine kinase.
    Smith L; Wong WC; Kiselyov AS; Burdzovic-Wizemann S; Mao Y; Xu Y; Duncton MA; Kim K; Piatnitski EL; Doody JF; Wang Y; Rosler RL; Milligan D; Columbus J; Balagtas C; Lee SP; Konovalov A; Hadari YR
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5102-6. PubMed ID: 16887347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the S4 and S1 prime subsite specificities in caspase-3 with aza-peptide epoxide inhibitors.
    Ganesan R; Jelakovic S; Campbell AJ; Li ZZ; Asgian JL; Powers JC; Grütter MG
    Biochemistry; 2006 Aug; 45(30):9059-67. PubMed ID: 16866351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5,5,6-Fused tricycles bearing imidazole and pyrazole 6-methylidene penems as broad-spectrum inhibitors of beta-lactamases.
    Venkatesan AM; Agarwal A; Abe T; Ushirogochi H; Ado M; Tsuyoshi T; Dos Santos O; Li Z; Francisco G; Lin YI; Petersen PJ; Yang Y; Weiss WJ; Shlaes DM; Mansour TS
    Bioorg Med Chem; 2008 Feb; 16(4):1890-902. PubMed ID: 18061461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 4-Substituted trinems as broad spectrum beta-lactamase inhibitors: structure-based design, synthesis, and biological activity.
    Plantan I; Selic L; Mesar T; Anderluh PS; Oblak M; Prezelj A; Hesse L; Andrejasic M; Vilar M; Turk D; Kocijan A; Prevec T; Vilfan G; Kocjan D; Copar A; Urleb U; Solmajer T
    J Med Chem; 2007 Aug; 50(17):4113-21. PubMed ID: 17665896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological activity of tricyclic analogues of 9-[[cis-1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]guanine.
    Ostrowski T; Golankiewicz B; De Clercq E; Balzarini J
    Bioorg Med Chem; 2006 May; 14(10):3535-42. PubMed ID: 16458009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of novel small-molecule inhibitors of human epidermal growth factor receptor-2: combined ligand and target-based approach.
    Gundla R; Kazemi R; Sanam R; Muttineni R; Sarma JA; Dayam R; Neamati N
    J Med Chem; 2008 Jun; 51(12):3367-77. PubMed ID: 18500794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors.
    Wang X; Sarris K; Kage K; Zhang D; Brown SP; Kolasa T; Surowy C; El Kouhen OF; Muchmore SW; Brioni JD; Stewart AO
    J Med Chem; 2009 Jan; 52(1):170-80. PubMed ID: 19072118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanomolar competitive inhibitors of Mycobacterium tuberculosis and Streptomyces coelicolor type II dehydroquinase.
    Prazeres VF; Sánchez-Sixto C; Castedo L; Lamb H; Hawkins AR; Riboldi-Tunnicliffe A; Coggins JR; Lapthorn AJ; González-Bello C
    ChemMedChem; 2007 Feb; 2(2):194-207. PubMed ID: 17245805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel potent macrocyclic inhibitors of the hepatitis C virus NS3 protease: use of cyclopentane and cyclopentene P2-motifs.
    Bäck M; Johansson PO; Wångsell F; Thorstensson F; Kvarnström I; Ayesa S; Wähling H; Pelcman M; Jansson K; Lindström S; Wallberg H; Classon B; Rydergård C; Vrang L; Hamelink E; Hallberg A; Rosenquist S; Samuelsson B
    Bioorg Med Chem; 2007 Nov; 15(22):7184-202. PubMed ID: 17845856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of tricyclic 1,3-oxazin-4-ones and kinetic analysis of cholesterol esterase and acetylcholinesterase inhibition.
    Pietsch M; Gütschow M
    J Med Chem; 2005 Dec; 48(26):8270-88. PubMed ID: 16366609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Organic azide inhibitors of cysteine proteases.
    Le GT; Abbenante G; Madala PK; Hoang HN; Fairlie DP
    J Am Chem Soc; 2006 Sep; 128(38):12396-7. PubMed ID: 16984172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and evaluation of novel 1-(2-acylhydrazinocarbonyl)-cycloalkyl carboxamides as interleukin-1beta converting enzyme (ICE) inhibitors.
    Soper DL; Sheville J; O'Neil SV; Wang Y; Laufersweiler MC; Oppong KA; Wos JA; Ellis CD; Fancher AN; Lu W; Suchanek MK; Wang RL; De B; Demuth TP
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4233-6. PubMed ID: 16782334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of potent, selective 4-fluoroproline-based thrombin inhibitors with improved metabolic stability.
    Staas DD; Savage KL; Sherman VL; Shimp HL; Lyle TA; Tran LO; Wiscount CM; McMasters DR; Sanderson PE; Williams PD; Lucas BJ; Krueger JA; Lewis SD; White RB; Yu S; Wong BK; Kochansky CJ; Anari MR; Yan Y; Vacca JP
    Bioorg Med Chem; 2006 Oct; 14(20):6900-16. PubMed ID: 16870455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of monoamine oxidase B by N-methyl-2-phenylmaleimides.
    Manley-King CI; Terre'Blanche G; Castagnoli N; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2009 Apr; 17(8):3104-10. PubMed ID: 19324554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel prostaglandin D synthase inhibitors generated by fragment-based drug design.
    Hohwy M; Spadola L; Lundquist B; Hawtin P; Dahmén J; Groth-Clausen I; Nilsson E; Persdotter S; von Wachenfeldt K; Folmer RH; Edman K
    J Med Chem; 2008 Apr; 51(7):2178-86. PubMed ID: 18341273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide.
    Murineddu G; Ruiu S; Loriga G; Manca I; Lazzari P; Reali R; Pani L; Toma L; Pinna GA
    J Med Chem; 2005 Nov; 48(23):7351-62. PubMed ID: 16279795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.